Contraception is an important consideration for many individuals and couples. As technology advances, so does the availability of new methods of contraception. One of the most recent developments is Nexplanon, a long-acting reversible contraceptive (LARC) that is inserted under the skin of the upper arm. This article will explore the benefits of Nexplanon and discuss the implications for the future of contraception.
Nexplanon is a type of LARC, which is a form of contraception that is inserted under the skin of the upper arm and can remain effective for up to three years. It is a small, flexible rod that is inserted just beneath the skin and releases progestin, a hormone that prevents pregnancy. It is a highly effective form of contraception, with a failure rate of less than 1%. Unlike other forms of contraception, such as the pill, Nexplanon does not require daily or weekly maintenance and does not interfere with sexual activity.
Nexplanon offers many benefits to users, including:
The development of Nexplanon has implications for the future of contraception. As a highly effective form of contraception that is easy to use and does not interfere with sexual activity, Nexplanon is likely to become increasingly popular in the future. Furthermore, the development of LARCs such as Nexplanon could lead to the development of other long-acting contraceptives, such as implants and intrauterine devices, which could offer even greater convenience and effectiveness.
Nexplanon is a highly effective form of contraception that offers many benefits to users. It is easy to use, does not interfere with sexual activity, and can remain effective for up to three years. The development of Nexplanon has implications for the future of contraception, as it could lead to the development of other long-acting contraceptives that offer even greater convenience and effectiveness.
1.
Aspirin Fails to Boost Survival in Colorectal Cancer Trial
2.
Do Anatomy Atlases Reflect Social Inequalities?
3.
A higher risk of chemotherapy-induced peripheral neuropathy is associated with a deficiency in vitamin D prior to treatment.
4.
Some triple negative breast cancers might be avoided by longer breastfeeding
5.
Quizartinib Benefit in AML Limited to FLT3-Mutated Subgroup
1.
Innovative Intraoperative Therapies in Neurosurgical Oncology: Advancing Precision and Outcomes
2.
Metabolic Competition Within the Tumor Ecosystem: Mechanisms, Clinical Relevance, and Therapeutic Advances
3.
Ferroptosis-Modulating Nanocarriers for Solid Tumor Therapy
4.
Unlocking the Mystery of Glanzmann Thrombasthenia: A New Hope for Patients
5.
KEYNOTE-826: Optimizing Outcomes in Persistent, Recurrent, or Metastatic Cervical Cancer
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Clinical Excellence in Hematology
2.
Navigating the Complexities of Ph Negative ALL - Part I
3.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VII
4.
Cost Burden/ Burden of Hospitalization For R/R ALL Patients
5.
Understanding the causes of anemia in adults beyond nutritional deficiencies
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation